Related references
Note: Only part of the references are listed.Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Dendritic cell-based vaccine efficacy: aiming for hot spots
Gabriela Andrea Pizzurro et al.
FRONTIERS IN IMMUNOLOGY (2015)
Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
Arne Kolstad et al.
BLOOD (2015)
New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
Katelyn T. Byrne et al.
Oncotarget (2015)
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D. Wolchok et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
Chemoimmunotherapy: reengineering tumor immunity
Gang Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Exploiting dendritic cells in the development of cancer vaccines
Laura Bracci et al.
EXPERT REVIEW OF VACCINES (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
Alice Hervieu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Which drug, and when, for patients with BRAF-mutant melanoma?
Sekwon Jang et al.
LANCET ONCOLOGY (2013)
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Immune Monitoring in Cancer Vaccine Clinical Trials: Critical Issues of Functional Flow Cytometry-Based Assays
Iole Macchia et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy
Kenichiro Hasumi et al.
ONCOIMMUNOLOGY (2013)
Regulatory dendritic cells in the tumor immunoenvironment
Galina V. Shurin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (EBRT) WITH INTRATUMORAL INJECTION OF DENDRITIC CELLS AS NEO-ADJUVANT TREATMENT OF HIGH-RISK SOFT TISSUE SARCOMA PATIENTS
Steven E. Finkelstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
Shinichi Fujiwara et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology
A. Farkas et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Claus Garbe et al.
ONCOLOGIST (2011)
Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12
Stefano M. Santini et al.
PLOS ONE (2011)
Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer
Adriana J. Michielsen et al.
PLOS ONE (2011)
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study
P. Quaglino et al.
ANNALS OF ONCOLOGY (2010)
LOX-1 as a natural IFN-α-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells
Stefania Parlato et al.
BLOOD (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers
Dean L. Mann et al.
CANCER VACCINES (2009)
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Lotte Engell-Noerregaard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells
Bianca Altvater et al.
CLINICAL CANCER RESEARCH (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells
A. Farkas et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo
Claudia Papewalis et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficient stimulation of T cell responses by human IFN-α-induced dendritic cells does not require toll-like receptor triggering
Laura Bracci et al.
JOURNAL OF IMMUNOTHERAPY (2008)
IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens
Caterina Lapenta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma
Tae-Hyung Lee et al.
IMMUNOLOGY LETTERS (2006)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles
K Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
WR Song et al.
CANCER RESEARCH (2005)
Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma
KW Chi et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas
G Mazzolini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity
KW Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
AMM Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2004)
Role of cross-talk between IFN-α-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens
D Tosi et al.
JOURNAL OF IMMUNOLOGY (2004)
Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response
L Santodonato et al.
JOURNAL OF IMMUNOLOGY (2003)
Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo
F Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1
KS Lang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
SM Santini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)